Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO), headquartered in France. Within Amatsigroup, we provide high-quality, customized and cost-effective drug development solutions, integrated under one roof, to small biotech and major (bio) pharmaceutical customers. Our innovative and flexible approach enables customers to speed up their drug development process, achieving key milestones in a timely manner.
The company has three strategic pillars:
• Drug substance process development and manufacturing for biologics.
• Pharmaceutical analysis solutions: fit-for-purpose method developments and validations, stability studies and Quality Control (QC).
• Formulation development and manufacturing of sterile and non-sterile clinical or small commercial batches.
Clients also benefit from complementary services such as in-life studies, bioanalysis and clinical trial supply (packaging & logistics). A broad scientific, technical and regulatory expertise, combined with proactive troubleshooting skills, are the key assets of the company. Our goal is to build a sustainable partnership with our customers to support their drug development pathway.